What is NDC 51655-966?

51655-966 is the product NDC for Glipizide, Glipizide 10 mg/1 tablet, film coated, extended release, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Glipizide?

135 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Glipizide NDC 51655-966 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)51655-966Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51655-0966Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51655-966-26	5165509662651655096626	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-966-26)Marketed from Jul 31, 2023
51655-966-52	5165509665251655096652	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-966-52)Marketed from Jun 27, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Glipizide
Generic name (nonproprietary): glipizide
Active ingredients: Glipizide — 10 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Northwind Health Company, LLCNDC labeler code 51655
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204720
Marketing start: Jun 27, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Sulfonylurea Compounds (Chemical structure)
Identifiers: Product ID 51655-966_4bc1b84a-aaee-d6e6-e063-6294a90a0762SPL ID 4bc1b84a-aaee-d6e6-e063-6294a90a0762SPL set ID ff9b3b7a-5ab1-45ec-e053-6294a90af426RxCUI 315107UNII X7WDT95N5C
Pharmacologic class: Sulfonylurea

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451655096626 followed by a unit qualifier and the quantity

Package 51655-0966-26. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

Glipizide extended-release tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Glipizide extended-release tablet is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus Limitations of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis 1.1 Limitations of Use Glipizide extended-release tablets are not recommended for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51655-966

What is NDC 51655-966?: 51655-966 is the product NDC for Glipizide, Glipizide 10 mg/1 tablet, film coated, extended release, listed with the FDA by Northwind Health Company, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Glipizide.
What is the active ingredient?: Glipizide.
Who is the labeler?: Northwind Health Company, LLC, NDC labeler code 51655. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Glipizide?: 135 other product NDCs are listed under this name. See all Glipizide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Glipizide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Glipizide	Glipizide 5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-117	11788-0117-0111788-0117-0511788-0117-10
Glipizide	Glipizide 10 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-118	11788-0118-00
Glipizide	Glipizide 2.5 mg/1	TabletOral	AiPing Pharmaceutical, Inc.	11788-120	11788-0120-0111788-0120-0511788-0120-10
Glipizide	Glipizide 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-579	72789-0579-3072789-0579-6072789-0579-86+3 more
Glipizide	Glipizide 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-580	72789-0580-3072789-0580-6072789-0580-86+3 more
Glipizide	Glipizide 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4178	68788-4178-0168788-4178-0368788-4178-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Coupler LLC	67046-0367	67046-0367-03
Glipizide	Glipizide 5 mg/1	TabletOral	Coupler LLC	67046-0236	67046-0236-03
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4061	68788-4061-0168788-4061-0368788-4061-06+2 more
Glipizide	Glipizide 10 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-4017	68788-4017-0168788-4017-0368788-4017-06+2 more

All 136 Glipizide NDCs

Other NDCs under ANDA 204720

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204720
Product	Strength	Form · route	Labeler	Product NDC
Glipizide	Glipizide 5 mg/1	Tablet, Film coated, Extended releaseOral	A-S Medication Solutions	50090-5040
Glipizide	Glipizide 10 mg/1	Tablet, Film coated, Extended releaseOral	A-S Medication Solutions	50090-5806
Glipizide	Glipizide 5 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-337
Glipizide	Glipizide 2.5 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	64980-279
Glipizide	Glipizide 5 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	64980-280
Glipizide	Glipizide 10 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	64980-281
Glipizide	Glipizide 10 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-7856
Glipizide	Glipizide 2.5 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-8487
Glipizide	Glipizide 5 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-1063
Glipizide	Glipizide 10 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-1848
Glipizide	Glipizide 2.5 mg/1	Tablet, Film coated, Extended releaseOral	REMEDYREPACK INC.	70518-2308
Glipizide	Glipizide 5 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-1031
Glipizide	Glipizide 2.5 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-1042
Glipizide	Glipizide 10 mg/1	Tablet, Film coated, Extended releaseOral	Bryant Ranch Prepack	71335-1130